
STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead Sciences over patents for HIV prevention.
News
The latest Healthcare & Biotech news, announcements and analysis from the conferences, expos and summits shaping the sector.
One short email. Top stories from the trade shows, conferences and summits shaping business worldwide. No fluff, no spam, unsubscribe anytime.
© 2026 Industry Events Worldwide. All rights reserved.